• Clario accelerates your clinical trial from initiation to implementation. LEARN MORE →

Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)

      Discover Clario's AI solutions, where innovation meets expertise. Since 2018, we have revolutionized clinical trial endpoint analyses with more than 30 AI-enabled solutions across 600+ active trials, enhancing data quality and patient privacy while expediting data collection processes.

      Go to page
    • Cardiac Safety
      • Cardiac Safety
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Image Repository
      • Imaging Platform
      • Image Workflow
      • Modalities
      • SMART Submit
    • Precision Motion for Clinical Trials
      • Precision Motion for Clinical Trials
      • Precision Motion: Scientific Consulting Services
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, etc.)
      • Home & Hybrid DCT Spirometry​
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials

      All the precision endpoint technology and services your virtual or hybrid trial needs to deliver more certain outcomes.

      Go to page
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology Clinical Trials
    • Ophthalmology
    • Respiratory Solutions
  • Resources
    • Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Security Governance
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Safety
      • Cardiac Safety
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Image Repository
      • Imaging Platform
      • Image Workflow
      • Modalities
      • SMART Submit
    • Precision Motion for Clinical Trials
      • Precision Motion for Clinical Trials
      • Precision Motion: Scientific Consulting Services
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, etc.)
      • Home & Hybrid DCT Spirometry​
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials
      • Decentralized Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology Clinical Trials
    • Ophthalmology
    • Respiratory Solutions
  • Resources
    • Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Security Governance
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home About Newsroom Clario Awarded Top Workplace Recognition by Energage

Clario Awarded Top Workplace Recognition by Energage

Input from Clario employees reveals high satisfaction with culture, leadership and opportunities to make an impact

PHILADELPHIA, PA – February 2, 2022 – Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, has been named a Top Workplace by Energage for the 2022 Top Workplaces USA national awards. The Top Workplace honor comes on the heels of Clario’s Chief Diversity, Inclusion and Sustainability Officer, Otis Johnson, being recognized as a Mogul 2021 Top DEI Leader.

Top Workplace winners are based on employee feedback gathered through a third-party survey administered by Energage, an employee engagement technology company. The survey measures 15 drivers of engaged cultures that are critical to the success of any organization, including values, innovation and leadership. 

“It’s an incredible honor for our employees to recognize Clario as a Top Workplace. It’s a testament to their excitement and our collective commitment to Clario’s purpose of transforming lives – both inside and outside our walls,” says Otis Johnson, Ph.D., Chief Diversity, Inclusion and Sustainability Officer at Clario. Johnson’s leadership and recent recognition as a Mogul 2021 Top DEI Leader demonstrates how Clario fosters a culture of diversity, equity and inclusion for its employees.

Clario’s purpose is to transform lives by unlocking better clinical evidence through technology. Employees’ connection with this purpose is a key reason they like working at Clario. Culture and leadership made Clario a standout organization for the Top Workplace honor. Employees reported that they feel listened to and supported, acknowledging managers’ dedication to collaboration and team building.

“This award is rooted in employee feedback, so we are extremely proud and thankful to be recognized as a Top Workplace by our people,” says Lynne Borthwick, Chief People Officer at Clario. “This is only the beginning for Clario. We strive to empower ownership and encourage our team to be courageously curious in their work. I’m excited to continue welcoming and investing in great talent who share our passion and purpose.”

The Top Workplaces national awards celebrate companies that create a positive change in the world by working together and prioritizing a people-centered culture. Clario employees help create belonging by championing change and togetherness through employee resource groups. Advancement and mentorship programs, such as the Emerging Leaders Program, actively elevate women and people of color into leadership at Clario. Clario has committed to hiring 40 percent people of color across all levels in 2022 and accelerating pay equity across the organization.

“Our people make us who we are,” says Joe Eazor, CEO at Clario. “Being recognized as a Top Workplace by our employees is a measure of how we uphold our core value of ‘People First, Always.’ We continue to put people first and invest in our employees through various opportunities, including career advancement, mentorship and employee resource groups.”

Visit clario.com/careers to learn more about working at Clario and our exciting career opportunities!


About Clario

Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.

Clario Media Contact

Suzanne Harris

Senior Director, Corporate Brand and Marketing

[email protected]

484-274-7333

Back to news
Share
Twitter Facebook LinkedIn

Latest News

See all news

Clario Reveals Updated Oncology Trial Solutions Portfolio: The Industry’s Widest Range of Endpoint Collection Technologies

September 1, 2023 Read more

Dr. Vince Clinical Research, Clario Form Strategic Partnership to Deliver Innovative Cardiac Assessments in Clinical Trials

August 29, 2023 Read more

A checklist for unlocking the promise of AI in clinical trials

August 22, 2023 Read more
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

Thanks for your form. Our team will be in touch very soon.

  • © 2023 Clario

    • Legal and Privacy Terms
    • Security Governance
    • Cookie Policy
    • Impressum

Please enter your business email before proceeding to xTalks to complete registration.

×